Linked Life Data

10537780

Source:http://linkedlifedata.com/resource/pubmed/id/10537780

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-7-13
pubmed:abstractText
During the past several decades, many individuals have noted that drusen may resolve after macular laser photocoagulation. The lack of effective therapies against choroidal neovascularization (CNV) due to age-related macular degeneration (AMD) has prompted many invesigators to explore strategies designed to prevent CNV in eyes with high-risk drusen. Currently, several pilot studies in the United States, Spain, Sweden, Australia, and the United Kingdom are in progress; the Choroidal Neovascularization Prevention Trial (CNVPT) is the largest pilot study to date and is detailed herein. A definitive study, the Complications of Age-Related Macular Degeneration Prevention Trial, aims to evaluate the effects of laser treatment in patients with bilateral drusen and will commence this year.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
T
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1040-8738
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
204-8
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Laser treatment in eyes with drusen.
pubmed:affiliation
Wills Eye Hospital, Philadelphia, Pennsylvania, USA. acho@att.net
pubmed:publicationType
Journal Article, Review